Pneumococcal Disease Vaccine Updates

CE

Pneumococcal Disease Prevention: Integrating the Latest Vaccine Updates Into Practice

Pharmacy Technicians: 1.50 contact hours (0.15 CEUs)

Pharmacists: 1.50 contact hours (0.15 CEUs)

Released: December 20, 2024

Expiration: December 19, 2025

Mary Barna Bridgeman
Mary Barna Bridgeman, PharmD, BCPS, BCGP
Richard H. Dang
Richard H. Dang, PharmD, APh, FCPhA
Jeff Goad
Jeff Goad, PharmD, MPH, FAPhA, FASHP, FISTM

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

For adults aged 65 yr or older, compared to PCV20, PCV21 has additional serotypes that provide coverage for what additional percentage of IPD cases?

2.

You are updating your institution’s protocol for adult pneumococcal vaccination. If following the current CDC recommendations, what age cutoff would you use for universal/routine PCV vaccination?

3.

A 72-yr-old patient presents at the pharmacy, who received a complete series of PCV13 and PPSV23 at age 65. Using shared clinical decision-making, which additional pneumococcal vaccines would be most appropriate?

4.

Which of the following statements is the best way to use motivational interviewing to address vaccine hesitancy? I understand your hesitance, but . . .

5.

I am aware of proven strategies I can use to address pneumococcal vaccine hesitancy among adults 50 yr or older.